These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25589551)

  • 1. Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.
    Balouz V; Cámara Mde L; Cánepa GE; Carmona SJ; Volcovich R; Gonzalez N; Altcheh J; Agüero F; Buscaglia CA
    Clin Vaccine Immunol; 2015 Mar; 22(3):304-12. PubMed ID: 25589551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of TSSA (trypomastigote small surface antigen) in Trypanosoma cruzi invasion of mammalian cells.
    Cánepa GE; Degese MS; Budu A; Garcia CR; Buscaglia CA
    Biochem J; 2012 Jun; 444(2):211-8. PubMed ID: 22428617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trypomastigote Small Surface Antigen (TSSA) regulates Trypanosoma cruzi infectivity and differentiation.
    Cámara MLM; Cánepa GE; Lantos AB; Balouz V; Yu H; Chen X; Campetella O; Mucci J; Buscaglia CA
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005856. PubMed ID: 28800609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.
    Balouz V; Melli LJ; Volcovich R; Moscatelli G; Moroni S; González N; Ballering G; Bisio M; Ciocchini AE; Buscaglia CA; Altcheh J
    J Clin Microbiol; 2017 Dec; 55(12):3444-3453. PubMed ID: 28978686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.
    Bhattacharyya T; Falconar AK; Luquetti AO; Costales JA; Grijalva MJ; Lewis MD; Messenger LA; Tran TT; Ramirez JD; Guhl F; Carrasco HJ; Diosque P; Garcia L; Litvinov SV; Miles MA
    PLoS Negl Trop Dis; 2014 May; 8(5):e2892. PubMed ID: 24852444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of molecular diversity of the Trypanosoma cruzi trypomastigote small surface antigen reveals novel epitopes, evidence of positive selection and potential implications for lineage-specific serology.
    Bhattacharyya T; Brooks J; Yeo M; Carrasco HJ; Lewis MD; Llewellyn MS; Miles MA
    Int J Parasitol; 2010 Jul; 40(8):921-8. PubMed ID: 20097201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
    Romer G; Bracco LA; Ricci AD; Balouz V; Berná L; Villar JC; Ramsey JM; Nolan MS; Torrico F; Kesper N; Altcheh J; Robello C; Buscaglia CA; Agüero F
    PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011542. PubMed ID: 37556493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.
    De Marchi CR; Di Noia JM; Frasch AC; Amato Neto V; Almeida IC; Buscaglia CA
    Clin Vaccine Immunol; 2011 Nov; 18(11):1850-5. PubMed ID: 21880857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.
    Bottino CG; Gomes LP; Pereira JB; Coura JR; Provance DW; De-Simone SG
    BMC Infect Dis; 2013 Dec; 13():568. PubMed ID: 24299278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi.
    Burns JM; Shreffler WG; Rosman DE; Sleath PR; March CJ; Reed SG
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1239-43. PubMed ID: 1371355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric synthetic peptides as antigens for detection of antibodies to Trypanosoma cruzi.
    Hernández Marin M; Hernández Spengler I; Ramos Martínez G; Pozo Peña L
    Biochem Biophys Res Commun; 2006 Jan; 339(1):89-92. PubMed ID: 16289376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of B-cell epitopes in a Trypanosoma cruzi immunodominant antigen expressed in natural infections.
    Lesénéchal M; Becquart L; Lacoux X; Ladavière L; Baida RC; Paranhos-Baccalà G; da Silveira JF
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):329-33. PubMed ID: 15699429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.
    Mendes TA; Reis Cunha JL; de Almeida Lourdes R; Rodrigues Luiz GF; Lemos LD; dos Santos AR; da Câmara AC; Galvão LM; Bern C; Gilman RH; Fujiwara RT; Gazzinelli RT; Bartholomeu DC
    PLoS Negl Trop Dis; 2013; 7(10):e2524. PubMed ID: 24205430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution profiling of linear B-cell epitopes from mucin-associated surface proteins (MASPs) of Trypanosoma cruzi during human infections.
    Durante IM; La Spina PE; Carmona SJ; Agüero F; Buscaglia CA
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005986. PubMed ID: 28961244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of a single repetitive unit of the B13 Trypanosoma cruzi antigen as fusions to Escherichia coli LamB protein.
    Pereira CM; Franco da Silveira J; Duranti M; Cunha-Neto E; Zingales B; Castilho BA
    FEMS Microbiol Lett; 2004 Jun; 235(2):237-42. PubMed ID: 15183869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool for the characterization of Trypanosoma cruzi strains and isolates.
    Kesper N; de Almeida KA; Stolf AM; Umezawa ES
    J Parasitol; 2000 Aug; 86(4):862-7. PubMed ID: 10958475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies.
    Cimino RO; Rumi MM; Ragone P; Lauthier J; D'Amato AA; Quiroga IR; Gil JF; Cajal SP; Acosta N; Juárez M; Krolewiecki A; Orellana V; Zacca R; Marcipar I; Diosque P; Nasser JR
    Parasitology; 2011 Jul; 138(8):995-1002. PubMed ID: 21518468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
    Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
    Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.